Skip to content

Long Term Evaluation of Human Acellular Dermal Matrix Allograft For Coverage of the Wound After Extensive Deep Burn

Long Term Evaluation of Human Acellular Dermal Matrix Allograft For Coverage of the Wound After Extensive Deep Burn

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01562119
Acronym
ADM
Enrollment
30
Registered
2012-03-23
Start date
2011-01-31
Completion date
2013-05-31
Last updated
2013-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn, Traumatic Implants

Keywords

Burns, Wound repair, Skin substitutes

Brief summary

The present study was to retrospectively evaluate the long-term outcomes of the cograft acellular dermal matrix (ADM) with autologous thin split-thickness skin for coverage of functional regional wounds in burned patients.

Detailed description

The potential of acellular dermal matrix (ADM) had been proved to improve cosmetic and functional outcomes, nevertheless, there had been few reports about the long term results of the morphological, histological and functional changes after placement. The present study was to retrospectively evaluate the long-term outcomes of the cograft acellular dermal matrix (ADM) with autologous thin split-thickness skin for coverage of functional regional wounds in burned patients.

Interventions

None listed

Sponsors

Tang-Du Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to 52 Years
Healthy volunteers
No

Inclusion criteria

* the patient's skin with ADM implant

Design outcomes

Primary

MeasureTime frame
Function of the region covered by human acellular dermal matrix allograftMarch, 2012 to May, 2013

Secondary

MeasureTime frame
Physical characteristics of the transplanted human acellular dermal matrix allograftMarch, 2012 to May, 2013

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026